placeholder image

A/PROF David Prior

Positions

  • Assessment of haemodynamics at rest and with exercise including correlation of non-invasive with invasive measurements
  • Changes in pulmonary pressure with exercise in normal subjects and patients with scleroderma and the utility of exercise stress and echocardiography t
  • Diagnosis of heart failure and pulmonary hypertension
  • Effects of endurance exercise on cardiac function and mechanisms of cardiac dysfunction following extreme exercise
  • Heart failure treatment
  • Non-invasive assessment of myocardial function in health and disease using cardiac ultrasound
  • Novel parameters of cardiac function including left ventricular torsion and their correlation with invasive measures of cardiac function

Overview

Affiliation

Member of

  • American College of Cardiology. Member 1999 -
  • American Society of Echocardiography. Member 1999 -
  • Australasian Society for Ultrasound in Medicine. Member 1995 -
  • Cardiac Society of Australia and New Zealand. Member 1994 -
  • Medical Board of Victoria. Registered 1988 -

Publications

Selected publications

Research

Investigator on

Additional Grant Information

  • The Cleveland Clinic Foundation Research Grants Committee. Prognostic value of color M-mode and tissue Doppler imaging to assess diastolic function in congestive heart failure due to impaired left ventricular systolic function. David Prior, Allan Klein, Randall Starling, Michelle Deguise, Jeremy Pereira. 2000, 1 year, $26,000.


    St Vincent’s Hospital Research Endowment Fund. Prediction of responses to beta-blocker therapy in heart failure using Doppler filling patterns of the left ventricle. David Prior, Andrew MacIsaac. 2001, 1 year, $8,000.
    National Heart Foundation of Australia. Amino-terminal pro-brain natriuretic (NT-proBNP) and heart disease: Evaluation of the utility of NT-proBNP in the diagnosis of “early” heart failure. DJ Campbell, AI MacIsaac, DL Prior. 2001 & 2002, $35,000 per annum.

    Sylvia & Charles Viertel Clinical Investigatorship. Value of NT pro-BNP assay for diagnosis of heart failure and the role of echocardiographic assessment of diastolic function in predicting response to beta-blockade in heart failure. David Prior 2002, $55,000.

    CVL Pfizer Cardiovascular Lipid Research Grant. The role of new and conventional echocardiographic measures of diastolic function in predicting response to beta-blockade and prognosis in heart failure. David Prior Andrew MacIsaac. 2002, $50,000.

    National Heart Foundation of Australia. New and conventional echocardiographic measures of diastolic function in predicting response to beta-blockade and prognosis in heart failure. David Prior, Andrew MacIsaac, David Kaye. 2002, $50,000; 2003, $42,735.

    National Health and Medical Research Council. Efficacy and mechanisms of exercise training in diastolic heart failure (301136) Thomas Marwick, David Prior, David Hare, Jeff Coombes, Dominic Leung, Brian Haluska. 2004 – 2006, $543,450.

    St Vincent’s Hospital Research Endowment Fund. Effect of ultra-end

       

Awards

Education and training

  • PhD, Monash University 1999
  • MBBS, Monash University 1987
  • BMedSc (Hons), Monash University 1987

Awards and honors

  • Fellow of the American College of Cardiology, 2009
  • Fellow of the Cardiac Society of Australia and New Zealand, 2004
  • Postgraduate Research Scholarship, Alfred Healthcare Foundation, 1998
  • Medical Postgraduate Scholarship, National Health and Medical Research Council, 1998
  • Travelling Fellowship, Sigma / Cardiac Society of Australia & New Zealand, 1997
  • Fellow of the Royal Australasian College of Physicians, 1995

Linkages

Supervision

Available for supervision

  • Y